State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Lung & Bronchus (Late Stage^), 2018-2022

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank

Explanation of Column Headers
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

US (SEER+NPCR)¹

• Rate : The incidence rate is 33.6 with a 95% confidence interval from 33.6 to 33.7 and 143,218 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A

Kentucky⁷

• Rate : The incidence rate is 56.3 with a 95% confidence interval from 55.4 to 57.2 and 3,344 average annual cases over 2018-2022.
• CI*Rank ⋔ : 1 (1, 1)
• Percent of Cases with Late Stage :

West Virginia²

• Rate : The incidence rate is 51.1 with a 95% confidence interval from 49.9 to 52.4 and 1,390 average annual cases over 2018-2022.
• CI*Rank ⋔ : 2 (2, 2)
• Percent of Cases with Late Stage :

Mississippi²

• Rate : The incidence rate is 45.7 with a 95% confidence interval from 44.8 to 46.7 and 1,745 average annual cases over 2018-2022.
• CI*Rank ⋔ : 3 (3, 4)
• Percent of Cases with Late Stage :

Missouri²

• Rate : The incidence rate is 44.2 with a 95% confidence interval from 43.6 to 44.9 and 3,648 average annual cases over 2018-2022.
• CI*Rank ⋔ : 4 (3, 7)
• Percent of Cases with Late Stage :

Indiana²

• Rate : The incidence rate is 44.0 with a 95% confidence interval from 43.4 to 44.7 and 3,787 average annual cases over 2018-2022.
• CI*Rank ⋔ : 5 (4, 8)
• Percent of Cases with Late Stage :

Louisiana⁷

• Rate : The incidence rate is 43.6 with a 95% confidence interval from 42.8 to 44.4 and 2,550 average annual cases over 2018-2022.
• CI*Rank ⋔ : 6 (4, 8)
• Percent of Cases with Late Stage :

Arkansas²

• Rate : The incidence rate is 43.3 with a 95% confidence interval from 42.4 to 44.2 and 1,736 average annual cases over 2018-2022.
• CI*Rank ⋔ : 7 (4, 9)
• Percent of Cases with Late Stage :

Maine²

• Rate : The incidence rate is 42.5 with a 95% confidence interval from 41.3 to 43.8 and 930 average annual cases over 2018-2022.
• CI*Rank ⋔ : 8 (4, 11)
• Percent of Cases with Late Stage :

Tennessee²

• Rate : The incidence rate is 42.3 with a 95% confidence interval from 41.7 to 43.0 and 3,832 average annual cases over 2018-2022.
• CI*Rank ⋔ : 9 (7, 10)
• Percent of Cases with Late Stage :

North Carolina²

• Rate : The incidence rate is 41.3 with a 95% confidence interval from 40.8 to 41.7 and 5,604 average annual cases over 2018-2022.
• CI*Rank ⋔ : 10 (9, 12)
• Percent of Cases with Late Stage :

Ohio²

• Rate : The incidence rate is 40.8 with a 95% confidence interval from 40.4 to 41.3 and 6,527 average annual cases over 2018-2022.
• CI*Rank ⋔ : 11 (10, 13)
• Percent of Cases with Late Stage :

Iowa⁷

• Rate : The incidence rate is 40.5 with a 95% confidence interval from 39.7 to 41.4 and 1,725 average annual cases over 2018-2022.
• CI*Rank ⋔ : 12 (9, 13)
• Percent of Cases with Late Stage :

Oklahoma²

• Rate : The incidence rate is 40.1 with a 95% confidence interval from 39.3 to 40.9 and 1,978 average annual cases over 2018-2022.
• CI*Rank ⋔ : 13 (10, 13)
• Percent of Cases with Late Stage :

Michigan²

• Rate : The incidence rate is 38.6 with a 95% confidence interval from 38.1 to 39.1 and 5,356 average annual cases over 2018-2022.
• CI*Rank ⋔ : 14 (14, 15)
• Percent of Cases with Late Stage :

Illinois⁷

• Rate : The incidence rate is 37.8 with a 95% confidence interval from 37.3 to 38.2 and 6,108 average annual cases over 2018-2022.
• CI*Rank ⋔ : 15 (14, 17)
• Percent of Cases with Late Stage :

Georgia⁷

• Rate : The incidence rate is 37.2 with a 95% confidence interval from 36.7 to 37.7 and 4,648 average annual cases over 2018-2022.
• CI*Rank ⋔ : 16 (15, 19)
• Percent of Cases with Late Stage :

South Carolina²

• Rate : The incidence rate is 36.7 with a 95% confidence interval from 36.1 to 37.4 and 2,630 average annual cases over 2018-2022.
• CI*Rank ⋔ : 17 (15, 21)
• Percent of Cases with Late Stage :

New Hampshire²

• Rate : The incidence rate is 36.4 with a 95% confidence interval from 35.2 to 37.7 and 743 average annual cases over 2018-2022.
• CI*Rank ⋔ : 18 (15, 24)
• Percent of Cases with Late Stage :

Pennsylvania²

• Rate : The incidence rate is 36.1 with a 95% confidence interval from 35.7 to 36.5 and 6,704 average annual cases over 2018-2022.
• CI*Rank ⋔ : 19 (17, 23)
• Percent of Cases with Late Stage :

Delaware²

• Rate : The incidence rate is 35.8 with a 95% confidence interval from 34.4 to 37.3 and 525 average annual cases over 2018-2022.
• CI*Rank ⋔ : 20 (15, 27)
• Percent of Cases with Late Stage :

Wisconsin²

• Rate : The incidence rate is 35.8 with a 95% confidence interval from 35.2 to 36.4 and 2,876 average annual cases over 2018-2022.
• CI*Rank ⋔ : 21 (17, 24)
• Percent of Cases with Late Stage :

South Dakota²

• Rate : The incidence rate is 35.2 with a 95% confidence interval from 33.6 to 36.8 and 411 average annual cases over 2018-2022.
• CI*Rank ⋔ : 22 (16, 30)
• Percent of Cases with Late Stage :

North Dakota²

• Rate : The incidence rate is 34.7 with a 95% confidence interval from 33.0 to 36.5 and 324 average annual cases over 2018-2022.
• CI*Rank ⋔ : 23 (16, 32)
• Percent of Cases with Late Stage :

Rhode Island²

• Rate : The incidence rate is 34.6 with a 95% confidence interval from 33.2 to 36.0 and 519 average annual cases over 2018-2022.
• CI*Rank ⋔ : 24 (18, 30)
• Percent of Cases with Late Stage :

Alabama²

• Rate : The incidence rate is 34.3 with a 95% confidence interval from 33.7 to 35.0 and 2,330 average annual cases over 2018-2022.
• CI*Rank ⋔ : 25 (22, 29)
• Percent of Cases with Late Stage :

Kansas²

• Rate : The incidence rate is 34.0 with a 95% confidence interval from 33.2 to 34.9 and 1,257 average annual cases over 2018-2022.
• CI*Rank ⋔ : 26 (22, 30)
• Percent of Cases with Late Stage :

Florida²

• Rate : The incidence rate is 33.7 with a 95% confidence interval from 33.4 to 34.0 and 11,267 average annual cases over 2018-2022.
• CI*Rank ⋔ : 27 (24, 30)
• Percent of Cases with Late Stage :

Vermont²

• Rate : The incidence rate is 33.5 with a 95% confidence interval from 31.8 to 35.2 and 327 average annual cases over 2018-2022.
• CI*Rank ⋔ : 28 (20, 36)
• Percent of Cases with Late Stage :

Alaska²

• Rate : The incidence rate is 33.3 with a 95% confidence interval from 31.4 to 35.3 and 254 average annual cases over 2018-2022.
• CI*Rank ⋔ : 29 (20, 38)
• Percent of Cases with Late Stage :

Connecticut⁷

• Rate : The incidence rate is 33.1 with a 95% confidence interval from 32.4 to 33.8 and 1,640 average annual cases over 2018-2022.
• CI*Rank ⋔ : 30 (25, 34)
• Percent of Cases with Late Stage :

Massachusetts²

• Rate : The incidence rate is 32.6 with a 95% confidence interval from 32.0 to 33.1 and 3,031 average annual cases over 2018-2022.
• CI*Rank ⋔ : 31 (28, 34)
• Percent of Cases with Late Stage :

New York⁷

• Rate : The incidence rate is 32.6 with a 95% confidence interval from 32.3 to 32.9 and 8,590 average annual cases over 2018-2022.
• CI*Rank ⋔ : 32 (28, 34)
• Percent of Cases with Late Stage :

Virginia²

• Rate : The incidence rate is 32.1 with a 95% confidence interval from 31.6 to 32.6 and 3,493 average annual cases over 2018-2022.
• CI*Rank ⋔ : 33 (29, 35)
• Percent of Cases with Late Stage :

Minnesota²

• Rate : The incidence rate is 32.0 with a 95% confidence interval from 31.4 to 32.6 and 2,340 average annual cases over 2018-2022.
• CI*Rank ⋔ : 34 (29, 36)
• Percent of Cases with Late Stage :

New Jersey⁷

• Rate : The incidence rate is 31.5 with a 95% confidence interval from 31.1 to 32.0 and 3,779 average annual cases over 2018-2022.
• CI*Rank ⋔ : 35 (33, 37)
• Percent of Cases with Late Stage :

Nebraska²

• Rate : The incidence rate is 31.0 with a 95% confidence interval from 30.0 to 32.0 and 756 average annual cases over 2018-2022.
• CI*Rank ⋔ : 36 (32, 39)
• Percent of Cases with Late Stage :

Maryland²

• Rate : The incidence rate is 30.9 with a 95% confidence interval from 30.3 to 31.5 and 2,420 average annual cases over 2018-2022.
• CI*Rank ⋔ : 37 (34, 39)
• Percent of Cases with Late Stage :

Washington¹

• Rate : The incidence rate is 30.5 with a 95% confidence interval from 30.0 to 31.0 and 2,882 average annual cases over 2018-2022.
• CI*Rank ⋔ : 38 (35, 39)
• Percent of Cases with Late Stage :

Idaho⁷

• Rate : The incidence rate is 29.7 with a 95% confidence interval from 28.7 to 30.7 and 676 average annual cases over 2018-2022.
• CI*Rank ⋔ : 39 (36, 42)
• Percent of Cases with Late Stage :

Texas⁷

• Rate : The incidence rate is 28.8 with a 95% confidence interval from 28.5 to 29.0 and 8,775 average annual cases over 2018-2022.
• CI*Rank ⋔ : 40 (39, 42)
• Percent of Cases with Late Stage :

Oregon²

• Rate : The incidence rate is 28.7 with a 95% confidence interval from 28.0 to 29.3 and 1,650 average annual cases over 2018-2022.
• CI*Rank ⋔ : 41 (39, 43)
• Percent of Cases with Late Stage :

Montana²

• Rate : The incidence rate is 27.8 with a 95% confidence interval from 26.7 to 29.1 and 440 average annual cases over 2018-2022.
• CI*Rank ⋔ : 42 (39, 44)
• Percent of Cases with Late Stage :

Hawaii⁷

• Rate : The incidence rate is 27.2 with a 95% confidence interval from 26.2 to 28.3 and 566 average annual cases over 2018-2022.
• CI*Rank ⋔ : 43 (41, 44)
• Percent of Cases with Late Stage :

District of Columbia²

• Rate : The incidence rate is 26.7 with a 95% confidence interval from 24.9 to 28.5 and 180 average annual cases over 2018-2022.
• CI*Rank ⋔ : 44 (40, 46)
• Percent of Cases with Late Stage :

Nevada²

• Rate : The incidence rate is 24.9 with a 95% confidence interval from 24.2 to 25.6 and 973 average annual cases over 2018-2022.
• CI*Rank ⋔ : 45 (44, 47)
• Percent of Cases with Late Stage :

Arizona²

• Rate : The incidence rate is 24.4 with a 95% confidence interval from 24.0 to 24.9 and 2,407 average annual cases over 2018-2022.
• CI*Rank ⋔ : 46 (44, 47)
• Percent of Cases with Late Stage :

California⁷

• Rate : The incidence rate is 23.8 with a 95% confidence interval from 23.6 to 24.0 and 10,828 average annual cases over 2018-2022.
• CI*Rank ⋔ : 47 (46, 48)
• Percent of Cases with Late Stage :

Wyoming²

• Rate : The incidence rate is 23.4 with a 95% confidence interval from 21.8 to 25.0 and 179 average annual cases over 2018-2022.
• CI*Rank ⋔ : 48 (44, 49)
• Percent of Cases with Late Stage :

Colorado²

• Rate : The incidence rate is 22.5 with a 95% confidence interval from 21.9 to 23.0 and 1,487 average annual cases over 2018-2022.
• CI*Rank ⋔ : 49 (48, 49)
• Percent of Cases with Late Stage :

New Mexico⁷

• Rate : The incidence rate is 19.0 with a 95% confidence interval from 18.3 to 19.8 and 554 average annual cases over 2018-2022.
• CI*Rank ⋔ : 50 (50, 50)
• Percent of Cases with Late Stage :

Utah⁷

• Rate : The incidence rate is 16.6 with a 95% confidence interval from 16.0 to 17.3 and 494 average annual cases over 2018-2022.
• CI*Rank ⋔ : 51 (51, 51)
• Percent of Cases with Late Stage :

Puerto Rico²

• Rate : The incidence rate is 7.2 with a 95% confidence interval from 6.9 to 7.6 and 370 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage :

Notes:
Created by statecancerprofiles.cancer.gov on 03/23/2026 2:57 pm.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

Source: SEER and NPCR data. For more specific information please see the table.

Data for United States does not include Puerto Rico.